- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03822000
Risk Factors and Complications Contributing to Mortality in Elderly Patients With Fall-Induced Femoral Fracture
January 28, 2019 updated by: Chang Gung Memorial Hospital
Risk Factors and Complications Contributing to Mortality in Elderly Patients With Fall-Induced Femoral Fracture: A Cross-sectional Analysis Based on Trauma Registered Data
This study aimed to identify the risk factors and complications associated with mortality in elderly patients with femoral fracture after a fall from the ground level.
Study Overview
Detailed Description
This retrospective study reviewed data pertaining to elderly patients aged ≥ 65 years who were admitted into a Level I trauma center, between January 1, 2009 and December 31, 2017.
Multivariate logistic regression analysis was performed to identify independent effects of univariate predictive variables on the occurrence of mortality.
Study Type
Observational
Enrollment (Actual)
2407
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Kaohsiung, Taiwan, 83301
- Kaohsiung Chang Gung Memorial Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years to 100 years (Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
This retrospective study reviewed data from 27,462 trauma patients registered between January 1, 2009 and December 31, 2016.
The inclusion criteria were age ≥65 years and hospitalization for the treatment of femoral fracture following a fall from standing height level (<1 m).
This study excluded those patients with a fall from ≥1 m as well as those for whom incomplete data were available.
Description
Inclusion Criteria:
- Patients with a fall from ≥1 m as well as those for whom incomplete data were available.
Exclusion Criteria:
- those patients with a fall from ≥1 m
- patients with incompleted data
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Elderly Patients with Femoral Fracture
Elderly patients with fall-induced femoral fracture.
Patients were categorized into two groups: death (n = 42) and survival (n = 2,365).
|
Elderly patients with fall-induced femoral fracture who were survived.
Elderly patients with fall-induced femoral fracture who were dead.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mortality
Time Frame: up tp 2 months
|
Mortality was used as the primary outcome.
|
up tp 2 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 11, 2019
Primary Completion (Actual)
January 28, 2019
Study Completion (Actual)
January 28, 2019
Study Registration Dates
First Submitted
January 28, 2019
First Submitted That Met QC Criteria
January 28, 2019
First Posted (Actual)
January 30, 2019
Study Record Updates
Last Update Posted (Actual)
January 30, 2019
Last Update Submitted That Met QC Criteria
January 28, 2019
Last Verified
January 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CDRPG8H0011-2
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Femoral Fractures
-
RegeneCure, Ltd.UnknownProximal (Subtrochanteric)Femoral Fractures | Distal Femoral FracturesIsrael
-
Johns Hopkins UniversityRecruitingFemoral Fracture | Femoral Neck Fractures | Intertrochanteric FracturesUnited States
-
Sundsvall HospitalCompletedFemoral Neck FractureSweden
-
Hospices Civils de LyonCompleted
-
Sundsvall HospitalCompletedHip Fracture | Femoral Neck Fracture | Periprosthetic Femoral Fracture
-
RenJi HospitalRecruiting
-
Sorlandet Hospital HFCompleted
-
Hartford HospitalZimmer BiometCompletedFemoral Neck FractureUnited States
-
First Hospitals affiliated to the China PLA General...Unknown
-
Danderyd HospitalCompletedFemoral Neck FractureSweden
Clinical Trials on Survival
-
German Resuscitation RegistryCompletedCardiac Arrest
-
Carnegie Mellon UniversityCompleted
-
University Hospital, MontpellierCompleted
-
University of Sao PauloCAIO SERGIO NAHAS; SERGIO CARLOS NAHAS; Ivan Cecconello; Ulysses Ribeiro JuniorUnknownLymph Node Disease | Cancer of RectumBrazil
-
Shanghai 10th People's HospitalCompleted
-
Grupo de Investigación Clínica en Oncología RadioterapiaCompletedChemoradiation | Surgery | Survival | Non-small-Cell Lung Carcinoma | Stage IIIA-N2Spain
-
University of RegensburgElse Kröner Fresenius FoundationUnknownHepatocellular Carcinoma
-
Carnegie Mellon UniversityCompleted
-
Carnegie Mellon UniversityCompleted